NEW YORK — Two weeks after the largest IPO in Wall Street history, analysts covering SpaceX have reached a rare kind of consensus: they all see a great company, and they cannot agree on what it is worth. Price targets on $SPCX now stretch from $62 to $310 — one of the widest dispersions on any large-cap stock — even as the rating skews firmly toward Buy.
The split is less a warning than a reflection of how new and how unusual SpaceX is as a public company, spanning rockets, a global internet network, and an AI division after its xAI combination. With little public history to model, the Street is left debating the future rather than the past.
A Bullish Consensus, a Huge Range
Of the analysts who have initiated coverage, the clear majority rate SpaceX a Buy, building on the first wave of Wall Street buy ratings that greeted the stock after its debut. The average 12-month target sits around $187.80, implying solid upside from current levels.
But the edges tell the story. The most bullish shop sees $310, betting that Starlink's cash flows, a Starship-enabled launch monopoly, and orbital AI data centers compound for years. The most bearish, including Morningstar's $62 fair value, argues the stock already prices in a decade of flawless execution. Both can point to the same balance sheet and reach opposite conclusions.
The Tape Today
SpaceX — NASDAQ: SPCX — traded near $157, off its post-IPO high but holding well above its $150 opening print from the June 12 debut, with a market value still north of $2 trillion. That keeps it among the largest public U.S. companies, ahead of Tesla by market cap. Tesla — NASDAQ: TSLA — changed hands in the low $370s, ranging between roughly $371 and $379 on the session for a market capitalization near $1.41 trillion, with the analyst average target around $421. Live quotes are available for $SPCX on Yahoo Finance, Google Finance, WSJ, and Nasdaq, and for $TSLA on Yahoo Finance and Nasdaq. Broader gauges $SPY and $QQQ were little changed.
Think in Decades
The dispersion echoes a message SpaceX leadership has hammered since the roadshow. President Gwynne Shotwell told new investors to think in decades, not quarters — a framing that helps explain why near-term targets vary so widely. When the bull case rests on markets that barely exist yet, like orbital compute and direct-to-cell connectivity, small changes in assumptions swing the math enormously.
For now, the wide range is arguably healthy: it means real two-sided debate rather than herd consensus, and it leaves room for the stock to surprise. As coverage deepens and the company posts its first quarters as a public entity, analyst surveys compiled by outlets like MarketBeat should narrow. Until then, $SPCX remains the market's biggest, most fascinating question mark — and plenty of investors are happy to bet on the long arc.
This article does not constitute financial advice. Readers are advised to do their own research before investing in the stock market. Prices cited are point-in-time snapshots and may be stale — always confirm on a live financial source.
